Acenxion Biosystems
Acenxion Biosystems is a privately funded medical device company that is developing rapid, gold standard, automated systems for phenotypic antimicrobial susceptibility testing (AST) and bacterial detection in blood cultures (Sepsis). Seamlessly fitting into current clinical workflows, Acenxion’s scalable fAST system(TM) reduces the time required for phenotypic testing to just 4-6 hours (versus 2 or more days), allowing clinicians rapid use of targeted precision treatment. Acenxion’s technology improves patient outcomes, reduces healthcare costs, and reduces the spread of antibiotic resistance, extending the useful life of antibiotics (Antibiotic Stewardship).
Industries
Nr. of Employees
small (1-50)
Products
Acenxion fAST System
A rapid and fully automated AST system that provides MIC profiles and interpretations for various organisms, including fastidious ones, with results in about 6 hours.
Acenxion BLUe Technology
A technology for direct detection of microbes in clinical samples using microfluidic channels and electrical signal methods, significantly reducing the time to detection.
Acenxion fAST System
A rapid and fully automated AST system that provides MIC profiles and interpretations for various organisms, including fastidious ones, with results in about 6 hours.
Acenxion BLUe Technology
A technology for direct detection of microbes in clinical samples using microfluidic channels and electrical signal methods, significantly reducing the time to detection.